Jump Trading’s Ocular Therapeutix OCUL Stock Holding History

Jump Trading’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39,255	Closed	-$156K	–	506
2019 Q1	$156K	Buy	+39,255	New	+$158K	0.05%	435

Other funds holding OCUL

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Trading's OCUL Position: Q2 2019 in Review

Jump Trading sold out of Ocular Therapeutix (OCUL) in Q2 2019, closing a stake of 39,255 shares — an estimated $156K sold.

Jump Trading first reported a position in OCUL in Q1 2019 and held it in 1 quarter. The position peaked at $156K in Q1 2019. 68 funds tracked by Wall St. Rank hold OCUL as of Q2 2019.

Jump Trading reported no remaining Ocular Therapeutix position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 39,255 Ocular Therapeutix shares in Q2 2019, an estimated $156K.
Jump Trading first reported a position in Ocular Therapeutix in Q1 2019 and held it in 1 quarter.
Jump Trading's Ocular Therapeutix position peaked at $156K in Q1 2019.
68 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.